Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EndoCeutics Inc.
Age
40–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Postmenopausal women (non-hysterectomized or hysterectomized)
Women between 40 and 75 years of age
Willing to participate in the study and sign an informed consent
Women who have self-identified symptom(s) of vaginal atrophy
For non-hysterectomized women, willing to have endometrial biopsy at baseline and end of study
You may not be if
Undiagnosed abnormal genital bleeding
Hypertension equal to or above 140/90 mm Hg
The administration of any investigational drug within 30 days of screening visit
Endometrial hyperplasia, cancer or endometrial histology showing proliferative, secretory or menstrual type characteristics at histologic evaluation of endometrial biopsy performed at screening
Clareo Health | Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
